|
BioHealth and Life Sciences Update - 5/12/16
|
Precertification for 50% Investor Incentive Tax Credit Begins Next Week
|
Precertification for companies seeking to enable their investors to use Maryland's 50% Biotechnology Investor Incentive Tax Credit (BIITC) begins next week. From May 18th thru May 25th, Maryland's Department of Commerce will accept Form B applications for QMBC (qualified Maryland biotechnology company) precertification. Precertification will occur as soon as the applications have been reviewed, and notifications will be sent no later than June 6, 2016 so that qualified companies are able to register with their investors for the queue related to funds available July 1, 2016. For more information, please check online or contact the Dept. of Commerce. |
|
BioHealth and Life Sciences News
|
|
|
Baltimore's Centrexion expands its pipeline of non-opioid, non-addictive pain treatments through acquisitions, and raises $17M--increasing its equity funding to date to $58M.
Gaithersburg's Sirnaomics raises $10M and forges a path to clinical development of its anti-fibrosis RNAi therapeutics.
Baltimore's Clear Guide Medical closes $3M Series A to support marketing of its FDA approved innovative CT-Ultrasound fusion and instrument-guidance systems.
Glenwood's HealthCare Interactive raises an additional $3.4M as part of its $11.4 M total Series A funding to accelerate the company's expansion in the population health and direct-contract primary care markets.
Frederick's BioFactura closes oversubscribed $1.8M Series A funding to advance its portfolio of generic biologics, known as biosimilars, to the advanced preclinical stages.
Rockville's Therabron Therapeutics receives FDA Fast Track Designation for rhCC10 specifically for the prevention of chronic lung disease related to premature birth.
Baltimore's Sisu Global Health receives $200K from the Abell Foundation to support its work developing medical devices for doctors in the developing world.
Rockville's Trophogen seeks $10-15M in Series B investments or pharmaceutical partnership to bring four advanced products to Phase 102 combined clinical trials by 2017-19.
Germantown's QIAGEN launches streamlined bioinformatics for RNA sequencing of liquid biopsies.
Baltimore's PathoVax is one of OneStart Americas' top-10 healthcare startups of 2016.
Silver Spring's PharmaCyte Biotech's live-cell encapsulation facility is commissioned for GMP manufacture.
Baltimore's Protenus receives the Rising Star Award from the Chesapeake Regional Tech Council's 2016 TechAwards.
Rockville's Rexahn Pharmaceuticals announces initiation of Phase Ib/IIa clinical trial of Its novel oral anti-cancer therapeutic RX-3117 in the treatment of pancreatic and bladder cancer.
Baltimore's Sonavex wins the first annual Maryland Regional Crab Trap Competition.
Rockville's REGENXBIO shares preclinical data supporting FDA discussions on advancing RGX-314 and RGX-121 gene therapies into human clinical trials.
Germantown's Amarex Clinical Research received 'approval' notification from the FDA for an IND application written and filed by Amarex on behalf of a biotech client related to GVHD, and is part of an IND application for Late Phase Clinical Development of a Mild Dementia approved by the FDA and designated as a Breakthrough Therapy.
The MD Dept. of Commerce has market research resources--Frost and Sullivan and
Medtrack --available to Maryland-based biohealth entrepreneurs at its offices in Baltimore and Rockville. Please schedule appointments in advance.
|
|
Upcoming Deadlines and Events
|
6/6-9 MD Pavilion and activities at BIO2016 in San Francisco (see details below)
|
Canon BioMedical (Rockville)
To view more job opportunities,
Kamtek (Frederick) please check at the
bottom of the MD COMMERCE
SoBran, Inc. (Bethesda) BioHealth and Life Sciences website. |
|
Promote Your Organization to 15K+ at BIO2016 in San Francisco
|
|
Would you like to promote your technology or services at the international BIO conference, June 6-9th in San Francisco? There is one booth space remaining in the Maryland Pavilion in addition to the following affordable promotion opportunities:
Logo Visibility ($250; no charge for Maryland Pavilion exhibitors)
Scroll of organization logo on screens at front and back of Maryland Pavilion when stage is not in use. (Logo may include tagline <25 characters.)
Format: EPS & JPG (hi-res)
Video ($500/video; no charge for Maryland Pavilion exhibitors) Presentation of 1-4 minute video on screens at front and back of Maryland Pavilion when stage is not in use. Up to three videos/organization. (Sound will be low or muted. Video should be engaging without sound.)
Format: MOV or MPEG -- 16:9 aspect ratio (1080p) Literature Display ($100; no charge for Maryland Pavilion exhibitors) One 8.5" x 11" piece in literature rack (company responsible for shipping and refills)
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
|
|
|
|
|
